Agroceutical Products Ltd

Agroceutical Products Ltd is developing a reliable UK supply of **galanthamine**, a licensed medicine used to treat symptoms of Alzheimer's disease and found naturally in daffodils. Our main research project, **GalanCEAmine**, uses controlled-environment farming and a new extraction process to increase the amount of this valuable molecule we can obtain fr...

**Bracken for the Circular Economy (BraCE)** is a project that transforms bracken, an invasive fern covering approximately 100,000 hectares in Wales, from a costly agricultural burden into a valuable resource for sustainable peat-free growing media. With government commitment to phase out peat use, there is urgent demand for alternatives to imported mater...

The **Wool2Lube Project** aims to address two critical challenges: the underutilization of Welsh sheep wool and the growing global demand for sustainable, eco-friendly lubricants. Welsh sheep farming is a cornerstone of the rural economy, producing over 16,500 tons of wool annually. However, much of this wool, particularly from hill and mountain sheep, is...

Galanthamine is a key treatment for Alzheimer's Disease, the leading cause of dementia and a leading cause of death in the UK. Daffodils are the principal natural source of galanthamine, but their production is constrained by a long production cycle, seasonality, and exposure to weather and crop disease related losses. Galanthamine production is heavily i...

As we age there is reduction in the effectiveness with which our gastrointestinal tract functions, which has the consequence of reducing the absorption of nutrients from our diet. This is one of the contributors to the malnutrition suffered by many older individuals. Interestingly the changes to gastrointestinal tract functioning also leads to increased i...

This is a 48-month feasibility research project which aims to develop tools which will contribute to the COP26 Global Methane Pledge of cutting global methane emissions by at least 30% by 2030\. The project will seek to develop a naturally sourced nutritional additive to reduce methane emissions from ruminants, which currently account for 80% of the total...

**NextGenGelCap** is aimed at developing a strong supply chain to support the local production and subsequent export of UK-produced nutraceuticals to the US-Canadian market. At the heart of the program is the development of a new encapsulation technique that will increase drastically the shelf-life of oxygen sensitive nutraceutical formulations, involving...

**DAFOMI** is a 5 months feasibility research programme to develop emerging solutions to secure post COVID recovery and sustainable increases in the production of milk and dairy products providing diversification opportunities for farming and employment challenged by COVID-19 and Brexit pressures. **DAFOMI** will directly address the disruption of the wid...

Awaiting Public Project Summary

To develop and document a set of records and standard operating procedures to enable galanthamine produced from daffodils to meet the regulatory requirements of the Medicines and Healthcare Regulatory Agency and the Food and Drug Administration.

Galantamine is a pharmaceutical product that had been an approved Alzheimer’s Disease treatment since 1998. Galantamine can be synthesised chemically but it is a difficult and expensive process. Producing galantamine from galanthamine extracted from plants is more cost effective, but supplies are limited. Daffodils are an economically feasible plant sourc...

This short feasibility project aim at improving the industrial process of extraction of Galanthamine, a Daffodil derived alkaloid, presently used for the treatment of moderate Alzheimer’s, the production of anti-nicotine patches, and hair growth stimulants for the cosmetic industry. Galanthamine is one of the few medical drugs that is approved by NICE to ...